All Releases
 |
Athersys Reports 2009 First Quarter Results
May 7, 2009
|
20.4 KB |
|
| |
CLEVELAND, May 7, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the quarter ended March 31, 2009.
First Quarter and Recent Highlights Include:
* Ongoing enrollment in two MultiStem(r) phase I clinical trials, for
the treatment of acute myocardial infarction ...
|
|
Athersys to Host First Quarter 2009 Financial Results Call
Apr 14, 2009
|
10.0 KB |
|
| |
CLEVELAND, Apr 14, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its first quarter 2009 financial results at approximately 4:00 PM (Eastern Time) on Thursday, May 7, 2009, and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van Bokkelen, Ch...
|
|
Athersys, Inc. (ATHX) Chairman and Chief Executive Officer to Ring The NASDAQ Stock Market Closing Bell
Apr 7, 2009
|
11.2 KB |
|
| |
ADVISORY, Apr 7, 2009 (GlobeNewswire via COMTEX News Network) --
What:
Gil Van Bokkelen, Chairman and Chief Executive Officer of Athersys,
Inc. (ATHX), will preside over the Closing Bell.
Where:
NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio
When:
Wednesday, April 8, 2009 at 3:45 p.m. to 4:00 p.m. ET
...
|
|
Reminder: Athersys' First Annual Investor Day On April 8, 2009 in New York City
Apr 7, 2009
|
16.1 KB |
|
| |
CLEVELAND, Apr 7, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced highlights for its first annual Investor Day being held at the Intercontinental Hotel on Wednesday, April 8th, 2009 in New York City. As a reminder, the meeting will begin promptly at 8:30 a.m. Eastern Time and end at approximately 11:30 a...
|
|
Athersys to Present At Cowen and Company 29th Annual Health Care Conference
Mar 13, 2009
|
10.0 KB |
|
| |
CLEVELAND, Mar 13, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will present at the Cowen and Company 29th Annual Health Care Conference, to be held March 16-19, 2009, at The Boston Marriott Copley Place.
William (B.J.) Lehmann, President and Chief Operating Officer, will present on Tuesday, Ma...
|
|
Athersys Reports Fourth Quarter and 2008 Annual Results
Mar 12, 2009
|
21.7 KB |
|
| |
CLEVELAND, Mar 12, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the fourth quarter of 2008 and for the year ended December 31, 2008.
Fourth Quarter and Recent Highlights Include:
* Continued enrollment in two MultiStem(r) phase I clinical trials,
for acute ...
|
|
Athersys to Host First Annual Investor Day to Highlight Progress in Stem Cell and Drug Development Programs
Mar 4, 2009
|
16.5 KB |
|
| |
CLEVELAND, Mar 4, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will host its first annual Investor Day being held at the Intercontinental Hotel on Wednesday, April 8th, 2009 in New York City. The meeting will begin promptly at 8:30 a.m. Eastern Time and end at approximately 11:30 a.m. Eastern Time....
|
|
Athersys to Host Fourth Quarter 2008 Financial Results Call
Feb 11, 2009
|
10.0 KB |
|
| |
CLEVELAND, Feb 11, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its fourth quarter 2008 financial results at approximately 4:00 PM (Eastern Time) on Thursday, March 12, 2009, and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van Bokkelen...
|
|
Athersys to Present At 4th Annual Stem Cell Summit
Jan 27, 2009
|
10.8 KB |
|
| |
CLEVELAND, Jan 27, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced that William (B.J.) Lehmann, President and Chief Operating Officer, will present at the 4th Annual Stem Cell Summit on Tuesday, February 17, 2009, at Bridgewaters, in New York City. The annual Stem Cell Summit is the premier gathering of ...
|
|
Athersys to Present At 5th Annual Cell and Gene Therapy Forum
Jan 9, 2009
|
9.9 KB |
|
| |
CLEVELAND, Jan 9, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced that Dr. Gil Van Bokkelen, Chairman & Chief Executive Officer, will present at the 5th annual Phacilitate Cell and Gene Therapy Forum in Washington D.C. on Monday, January 26th, 2009. Dr. Van Bokkelen will present on recent progress in the...
|
|
Athersys Receives IND Authorization for Multistem in Treatment of Ischemic Stroke
Dec 11, 2008
|
15.6 KB |
|
| |
CLEVELAND, Dec 11, 2008 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has received authorization from the U.S. Food and Drug Administration (FDA) to begin a Phase I clinical trial evaluating the safety of administration of its "off-the-shelf" adult stem cell product, MultiStem(r), in the treatment o...
|
|
Athersys to Present At Lambert-Edwards SMID-West Stock Conference
Dec 8, 2008
|
9.6 KB |
|
| |
CLEVELAND, Dec 8, 2008 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced that William (B.J.) Lehmann, President and Chief Operating Officer, will present to investors and analysts at the Lambert-Edwards SMID-West Stock Conference, to be held December 11, 2009, at the Palmer House Hilton Hotel in Chicago, Illino...
|
|
Athersys to Participate At RBC Capital Markets 2008 Healthcare Conference
Dec 4, 2008
|
9.6 KB |
|
| |
CLEVELAND, Dec 4, 2008 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will participate at the RBC Capital Markets 2008 Healthcare Conference, to be held December 10-11, 2008, at the Westin Times Square hotel in New York City.
Gil Van Bokkelen, Chairman and Chief Executive of Athersys, will participate...
|
|
Athersys Announces Clinical Development Milestone in Bristol-Myers Squibb Discovery Alliance
Nov 12, 2008
|
12.1 KB |
|
| |
CLEVELAND, Nov 12, 2008 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced the achievement of another clinical development milestone related to its discovery alliance with Bristol-Myers Squibb Company (NYSE:BMY). Bristol-Myers Squibb notified the Company that it has initiated a phase II trial for a small molecul...
|
|
Athersys to Present At Lazard Capital Markets Annual Healthcare Conference
Nov 11, 2008
|
9.5 KB |
|
| |
CLEVELAND, Nov 11, 2008 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will present at the Lazard Capital Markets 5th Annual Healthcare Conference, to be held November 18-19, 2008, at The St. Regis hotel in New York City.
Gil Van Bokkelen, Chairman and Chief Executive, and William (B.J.) Lehmann, Pres...
|
|
Athersys Reports 2008 Third Quarter Results
Nov 10, 2008
|
71.3 KB |
|
| |
Cleveland, OHIO, (November 10, 2008) - Athersys, Inc. (NASDAQ: ATHX) today announced its results for the quarter ended September 30, 2008 and provided an update on key clinical development programs, including ATHX-105 and MultiStem.
In the third quarter, the Company filed an Investigational New Drug (IND) application for a Phase ...
|
|
Athersys Awarded 2008 Product Innovation of the Year by Frost & Sullivan
Oct 29, 2008
|
12.2 KB |
|
| |
CLEVELAND, Ohio, Oct 29, 2008 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it has been selected by Frost & Sullivan to receive the 2008 North American Product Innovation of the Year Award. The Company was selected in recognition of its novel stem cell product, MultiStem(r), a therapeutic product candidate ...
|
|
Athersys to Present at Seventh Annual BIO Investor Forum
Oct 21, 2008
|
8.3 KB |
|
| |
CLEVELAND, Oct 21, 2008 (BUSINESS WIRE) -- Athersys, Inc. (NASDAQ: ATHX) today announced it will present at the Seventh Annual BIO Investor Forum, to be held October 29-31st, 2008, at The Palace Hotel in San Francisco. Gil Van Bokkelen, Chairman and Chief Executive, will present on Thursday, October 30th, at 8:00 AM (Pacific Time). More information...
|
|
Athersys Announces Initial Patient Dosing of MultiStem(r) in Phase I Acute Myocardial Infarction Trial
Oct 14, 2008
|
12.2 KB |
|
| |
CLEVELAND, Oct 14, 2008 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced the presentation of data from its ongoing phase I clinical trial of MultiStem(r) for individuals following acute myocardial infarction (AMI). Marc Penn, M.D., Ph.D., Director of the Bakken Heart-Brain Institute at the Cleveland Clinic and...
|
|
Athersys to Host Third Quarter 2008 Financial Results Call
Oct 10, 2008
|
9.3 KB |
|
| |
CLEVELAND, Oct 10, 2008 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its third quarter 2008 financial results at approximately 4:00 PM (Eastern Time) on Monday, November 10, 2008, and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van Bokkelen...
|
|
|
= add release to Briefcase |
|
 |
|
Jul 2, 2009
10:15 AM ET
$0.89  0.01
Quotes delayed at least 20 minutes.
Information provided by eSignal.
|
|
 |
|
